Analysis of Cardiac Function in Patients with Alcoholic Cirrhosis
Creators
- 1. Assistant Professor, Department of Medicine, Darbhanga Medical College and Hospital, Laheriasarai, Bihar
- 2. Professor, Department of Medicine, Darbhanga Medical College and Hospital, Laheriasarai, Bihar
Description
Background: Liver cirrhosis is a condition that is frequently seen in clinical settings and causes a considerable amount of morbidity and mortality worldwide. This is a slowly progressing, chronic illness that affects the liver in a diffuse manner. It is linked to nodule formation; excessive collagen deposition that causes fibrosis, liver cell degeneration, and abnormal vascular architecture that alters hemodynamics. The aim of the present study is to evaluate cardiac function in liver cirrhosis patients. Methods: Between April 2023 and March 2024, 74 patients with a diagnosis of liver cirrhosis who were admitted to the Department of Medicine at the DMCH in Laheriasarai, Bihar, participated in a cross-sectional study. Results: 59 cases (79.73%) in all had an LVDD diagnosis. Of them, Stage 1 LVDD (impaired relaxation) accounted for 47.29% of cases, Stage 2 LVDD (pseudo normal) for 31.08%, and Stage 3 LVDD (severe restrictive type) for just one patient. Conclusion: While systolic function is preserved until severe hepatic failure, left ventricular diastolic impairment is frequently linked to the progression of hepatic dysfunction.
Abstract (English)
Background: Liver cirrhosis is a condition that is frequently seen in clinical settings and causes a considerable amount of morbidity and mortality worldwide. This is a slowly progressing, chronic illness that affects the liver in a diffuse manner. It is linked to nodule formation; excessive collagen deposition that causes fibrosis, liver cell degeneration, and abnormal vascular architecture that alters hemodynamics. The aim of the present study is to evaluate cardiac function in liver cirrhosis patients. Methods: Between April 2023 and March 2024, 74 patients with a diagnosis of liver cirrhosis who were admitted to the Department of Medicine at the DMCH in Laheriasarai, Bihar, participated in a cross-sectional study. Results: 59 cases (79.73%) in all had an LVDD diagnosis. Of them, Stage 1 LVDD (impaired relaxation) accounted for 47.29% of cases, Stage 2 LVDD (pseudo normal) for 31.08%, and Stage 3 LVDD (severe restrictive type) for just one patient. Conclusion: While systolic function is preserved until severe hepatic failure, left ventricular diastolic impairment is frequently linked to the progression of hepatic dysfunction.
Files
IJPCR,Vol16,Issue6,Article55.pdf
Files
(304.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:98731de7b458450fb8c46dd0ab194b65
|
304.2 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-05-26
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue6,Article55.pdf
- Development Status
- Active
References
- 1. Milani A, Zaccaria R, Bombardieri G, Gasbarrini A, Pola P. Cirrhotic cardiomyopathy. Dig Liver Dis 2007; 39:507-15. 2. Baik SK, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Orphanet J Rare Dis 2007; 2:15. 3. Krag A, Bendtsen F, Mortensen C, Henriksen JH, Møller S. Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis. Eur J Gastroenterol Hepatol 2010; 22:1085-92. 4. Bernardi M, Maggioli C, Dibra V, Zaccherini G. QT interval prolongation in liver cirrhosis: Innocent bystander or serious threat? Expert Rev Gastroenterol Hepatol 2012; 6:57-66. 5. Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 2007; 56:869-75. 6. Krag A, Bendtsen F, Henriksen JH, Møller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 2010; 59:105-10. 7. Bacon RB. Cirrhosis and its complications. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison's Principals of Internal Medicine. 19th ed., Vol. 2. New York: McGraw Hill; 2015. p. 2058. 8. Dhangar V, Nayak K, Khaini P, Srivastav V. Echo study in patients with cirrhosis of liver. Natl J Med Res 2014; 4:241-3. 9. Patil S, Lal B, Pandey M, Haldia SS, Rishi JP. A clinical study of cardiovascular dysfunction in patients of cirrhosis of liver. Ann Int Med Den Res 2016; 2:212-5. 10. Venkateshwarlu N, Gandiah P, Indira G, Sivarajappa P, Prabhakar KK. Cardiac abnormalities in patients with cirrhosis. Indian J Life Sci 2013; 3:105. 11. Gupta R, Singhal A, Jatav O. Echocardiographic changes in alcoholic Liver disease. Int J Multidisc Res Dev 2015; 2:72-9. 12. Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000;95:3200- 3205 13. Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhosis patients with or without ascites. Hepatology 1997; 26:1131-1137 14. Arbol LR, Achecar L, Serradilla R, et al. Diastolic dysfunction is a predicter of poor outcomes in patients with cirrhosis, portal hypertension and a normal creatinine. Hepatology 2013; 58:1732-1741. 15. Papastergiou V, Skorda L, Lisgos P, et al. Ultrasonographic prevalence and factors predicting left ventricular diastolic dysfunction in patients with liver cirrhosis: Is there a correlation between the grade of diastolic dysfunction and the grade of liver disease? Scientific World Journal 2012; 2012:615057.